Scolaris Content Display Scolaris Content Display

استفاده از کاتترهای آغشته به هپارین برای افزایش باز ماندن کاتترهای ورید مرکزی در کودکان

Appendices

Appendix 1. CENTRAL search strategy

#1

MeSH descriptor: [Catheterization, Central Venous] explode all trees

718

#2

catheter* or device or line:ti,ab,kw (Word variations have been searched)

36000

#3

central near/2 venous:ti,ab,kw (Word variations have been searched)

1899

#4

#1 or #2 or #3

36670

#5

MeSH descriptor: [Coated Materials, Biocompatible] explode all trees

475

#6

*bond*:ti,ab,kw (Word variations have been searched)

2609

#7

coat*:ti,ab,kw (Word variations have been searched)

3394

#8

impregnat*:ti,ab,kw (Word variations have been searched)

570

#9

#5 or #6 or #7 or #8

6342

#10

MeSH descriptor: [Heparin] explode all trees

3985

#11

*heparin*:ti,ab,kw (Word variations have been searched)

7414

#12

heparin near/2 bonded

81

#13

#10 or #11 or #12

7661

#14

#4 and #9 and #13 in Trials

51

Appendix 2. MEDLINE search strategy

Database: Ovid MEDLINE(R) <1946 to August Week 3 2013>

Search Strategy:

‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐

1 exp Catheterization, Central Venous/ (11728)

2 (catheter$ or device or line).ti,ab. (655610)

3 (central adj2 venous).ti,ab. (17481)

4 or/1‐3 (664159)

5 exp Coated Materials, Biocompatible/ (10092)

6 bond$.ti,ab. (148604)

7 coat$.ti,ab. (105750)

8 impregnat$.ti,ab. (12101)

9 or/5‐8 (266464)

10 exp Heparin/ (56968)

11 heparin.ti,ab. (63062)

12 10 or 11 (82545)

13 4 and 9 and 12 (405)

14 randomized controlled trial.pt. (382845)

15 controlled clinical trial.pt. (88922)

16 randomized.ab. (281449)

17 placebo.ab. (154031)

18 clinical trials as topic.sh. (173835)

19 randomly.ab. (195836)

20 trial.ti. (121954)

21 or/14‐20 (879793)

22 (animals not (humans and animals)).sh. (3929804)

23 21 not 22 (810811)

24 13 and 23 (51)

Study flow diagram for updated review.
Figuras y tablas -
Figure 1

Study flow diagram for updated review.

Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.
Figuras y tablas -
Figure 2

Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.

Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
Figuras y tablas -
Figure 3

Risk of bias summary: review authors' judgements about each risk of bias item for each included study.

Forest plot of comparison: 1 Heparin‐bonded catheter versus non‐heparin bonded catheters, outcome: 1.1 Catheter‐related thrombosis at any time during catheter stay.
Figuras y tablas -
Figure 4

Forest plot of comparison: 1 Heparin‐bonded catheter versus non‐heparin bonded catheters, outcome: 1.1 Catheter‐related thrombosis at any time during catheter stay.

Forest plot of comparison: 1 Heparin‐bonded catheter versus non‐heparin bonded catheters, outcome: 1.8 Thrombocytopenia after catheter insertion.
Figuras y tablas -
Figure 5

Forest plot of comparison: 1 Heparin‐bonded catheter versus non‐heparin bonded catheters, outcome: 1.8 Thrombocytopenia after catheter insertion.

Comparison 1 Heparin‐bonded catheter versus non‐heparin bonded catheters, Outcome 1 Catheter‐related thrombosis at any time during catheter stay.
Figuras y tablas -
Analysis 1.1

Comparison 1 Heparin‐bonded catheter versus non‐heparin bonded catheters, Outcome 1 Catheter‐related thrombosis at any time during catheter stay.

Comparison 1 Heparin‐bonded catheter versus non‐heparin bonded catheters, Outcome 2 Catheter‐related thrombosis within one week of catheter insertion.
Figuras y tablas -
Analysis 1.2

Comparison 1 Heparin‐bonded catheter versus non‐heparin bonded catheters, Outcome 2 Catheter‐related thrombosis within one week of catheter insertion.

Comparison 1 Heparin‐bonded catheter versus non‐heparin bonded catheters, Outcome 3 Catheter‐related thrombosis after one week of insertion.
Figuras y tablas -
Analysis 1.3

Comparison 1 Heparin‐bonded catheter versus non‐heparin bonded catheters, Outcome 3 Catheter‐related thrombosis after one week of insertion.

Comparison 1 Heparin‐bonded catheter versus non‐heparin bonded catheters, Outcome 4 Occlusion of catheter within one week of catheter insertion.
Figuras y tablas -
Analysis 1.4

Comparison 1 Heparin‐bonded catheter versus non‐heparin bonded catheters, Outcome 4 Occlusion of catheter within one week of catheter insertion.

Comparison 1 Heparin‐bonded catheter versus non‐heparin bonded catheters, Outcome 5 Occlusion of catheter after one week of catheter insertion.
Figuras y tablas -
Analysis 1.5

Comparison 1 Heparin‐bonded catheter versus non‐heparin bonded catheters, Outcome 5 Occlusion of catheter after one week of catheter insertion.

Comparison 1 Heparin‐bonded catheter versus non‐heparin bonded catheters, Outcome 6 Catheter‐related blood stream infection.
Figuras y tablas -
Analysis 1.6

Comparison 1 Heparin‐bonded catheter versus non‐heparin bonded catheters, Outcome 6 Catheter‐related blood stream infection.

Comparison 1 Heparin‐bonded catheter versus non‐heparin bonded catheters, Outcome 7 Colonization of catheter with microbes.
Figuras y tablas -
Analysis 1.7

Comparison 1 Heparin‐bonded catheter versus non‐heparin bonded catheters, Outcome 7 Colonization of catheter with microbes.

Comparison 1 Heparin‐bonded catheter versus non‐heparin bonded catheters, Outcome 8 Thrombocytopenia after catheter insertion.
Figuras y tablas -
Analysis 1.8

Comparison 1 Heparin‐bonded catheter versus non‐heparin bonded catheters, Outcome 8 Thrombocytopenia after catheter insertion.

Heparin‐bonded catheter compared with non‐heparin bonded catheter for central venous catheter in children

Participant or population: Children with central venous catheter

Settings: Hospital

Intervention: Heparin‐bonded central venous catheter

Comparison: Non‐heparin bonded central venous catheter

Outcomes

Illustrative comparative risks* (95% CI)

Relative effect
(95% CI)

No of Participants
(studies)

Quality of the evidence
(GRADE)

Comments

Assumed risk

Corresponding risk

Non heparin‐bonded catheter

Heparin‐bonded catheter

Days of catheter patency

median of 6 days

median of 7 days

200 (1 study)

⊕⊕⊝⊝
low

Only one study reported this outcome

Catheter‐related thrombosis at any time during catheter stay

175 per 1000

59 per 1000

(2 to 1344)

RR 0.34 (0.01 to 7.68)

287 (2 studies)

⊕⊕⊕⊝
moderate

Occlusion of catheter within one week of catheter insertion

78 per 1000

5 per 1000

(0 to 83)

RR 0.06 (0.00 to 1.07)

200 (1 study)

⊕⊕⊝⊝
low

Only one study reported this outcome

Catheter‐related blood stream infection and CVC‐related colonization

184 per 1000

11 per 1000

(2 to 75)

RR 0.06 (0.01 to 0.41)

200 (1 study)

⊕⊕⊝⊝
low

Only one study reported this outcome

Side effects: Thrombocytopenia after catheter insertion

133 per 1000

97 per 1000

(50 to 85)

RR 0.73 (0.38 to 1.39)

287 (2 studies)

⊕⊕⊝⊝
low

No systematic evaluation of thrombocytopenia was conducted in either study

*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval; RR: Risk Ratio

GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.

Figuras y tablas -
Comparison 1. Heparin‐bonded catheter versus non‐heparin bonded catheters

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Catheter‐related thrombosis at any time during catheter stay Show forest plot

2

287

Risk Ratio (M‐H, Random, 95% CI)

0.34 [0.01, 7.68]

2 Catheter‐related thrombosis within one week of catheter insertion Show forest plot

1

Risk Ratio (M‐H, Fixed, 95% CI)

Totals not selected

3 Catheter‐related thrombosis after one week of insertion Show forest plot

1

Risk Ratio (M‐H, Fixed, 95% CI)

Totals not selected

4 Occlusion of catheter within one week of catheter insertion Show forest plot

1

Risk Ratio (M‐H, Fixed, 95% CI)

Totals not selected

5 Occlusion of catheter after one week of catheter insertion Show forest plot

1

Risk Ratio (M‐H, Fixed, 95% CI)

Totals not selected

6 Catheter‐related blood stream infection Show forest plot

1

Risk Ratio (M‐H, Fixed, 95% CI)

Totals not selected

7 Colonization of catheter with microbes Show forest plot

1

Risk Ratio (M‐H, Fixed, 95% CI)

Totals not selected

8 Thrombocytopenia after catheter insertion Show forest plot

2

287

Risk Ratio (M‐H, Random, 95% CI)

0.73 [0.38, 1.39]

Figuras y tablas -
Comparison 1. Heparin‐bonded catheter versus non‐heparin bonded catheters